166 related articles for article (PubMed ID: 34534614)
1. Can the mean linear energy transfer of organs be directly related to patient toxicities for current head and neck cancer intensity-modulated proton therapy practice?
Wagenaar D; Schuit E; van der Schaaf A; Langendijk JA; Both S
Radiother Oncol; 2021 Dec; 165():159-165. PubMed ID: 34534614
[TBL] [Abstract][Full Text] [Related]
2. Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment-related toxicities following proton therapy for intracranial tumors.
Ödén J; Toma-Dasu I; Witt Nyström P; Traneus E; Dasu A
Med Phys; 2020 Feb; 47(2):342-351. PubMed ID: 31705671
[TBL] [Abstract][Full Text] [Related]
3. Introducing Proton Track-End Objectives in Intensity Modulated Proton Therapy Optimization to Reduce Linear Energy Transfer and Relative Biological Effectiveness in Critical Structures.
Traneus E; Ödén J
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):747-757. PubMed ID: 30395906
[TBL] [Abstract][Full Text] [Related]
4. Impact of range uncertainty on clinical distributions of linear energy transfer and biological effectiveness in proton therapy.
Hahn C; Eulitz J; Peters N; Wohlfahrt P; Enghardt W; Richter C; Lühr A
Med Phys; 2020 Dec; 47(12):6151-6162. PubMed ID: 33118161
[TBL] [Abstract][Full Text] [Related]
5. Validation of linear energy transfer computed in a Monte Carlo dose engine of a commercial treatment planning system.
Wagenaar D; Tran LT; Meijers A; Marmitt GG; Souris K; Bolst D; James B; Biasi G; Povoli M; Kok A; Traneus E; van Goethem MJ; Langendijk JA; Rosenfeld AB; Both S
Phys Med Biol; 2020 Jan; 65(2):025006. PubMed ID: 31801119
[TBL] [Abstract][Full Text] [Related]
6. Dose averaged linear energy transfer optimization for large sacral chordomas in carbon ion therapy.
Schafasand M; Resch AF; Nachankar A; Góra J; Martino G; Traneus E; Glimelius L; Georg D; Fossati P; Carlino A; Stock M
Med Phys; 2024 Jun; 51(6):3950-3960. PubMed ID: 38696546
[TBL] [Abstract][Full Text] [Related]
7. The dirty and clean dose concept: Towards creating proton therapy treatment plans with a photon-like dose response.
Heuchel L; Hahn C; Ödén J; Traneus E; Wulff J; Timmermann B; Bäumer C; Lühr A
Med Phys; 2024 Jan; 51(1):622-636. PubMed ID: 37877574
[TBL] [Abstract][Full Text] [Related]
8. Difference in LET-based biological doses between IMPT optimization techniques: Robust and PTV-based optimizations.
Hirayama S; Matsuura T; Yasuda K; Takao S; Fujii T; Miyamoto N; Umegaki K; Shimizu S
J Appl Clin Med Phys; 2020 Apr; 21(4):42-50. PubMed ID: 32150329
[TBL] [Abstract][Full Text] [Related]
9. Robust intensity-modulated proton therapy to reduce high linear energy transfer in organs at risk.
An Y; Shan J; Patel SH; Wong W; Schild SE; Ding X; Bues M; Liu W
Med Phys; 2017 Dec; 44(12):6138-6147. PubMed ID: 28976574
[TBL] [Abstract][Full Text] [Related]
10. Linear energy transfer-guided optimization in intensity modulated proton therapy: feasibility study and clinical potential.
Giantsoudi D; Grassberger C; Craft D; Niemierko A; Trofimov A; Paganetti H
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):216-22. PubMed ID: 23790771
[TBL] [Abstract][Full Text] [Related]
11. Incorporation of the LETd-weighted biological dose in the evaluation of breast intensity-modulated proton therapy plans.
Liu C; Zheng D; Bradley JA; Mailhot Vega RB; Zhang Y; Indelicato DJ; Mendenhall N; Liang X
Acta Oncol; 2021 Feb; 60(2):252-259. PubMed ID: 33063569
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of dose-averaged linear energy transfer (LET
Rana S; Traneus E; Jackson M; Tran L; Rosenfeld AB
Med Phys; 2022 May; 49(5):3444-3456. PubMed ID: 35194809
[TBL] [Abstract][Full Text] [Related]
13. Interlaced proton grid therapy - Linear energy transfer and relative biological effectiveness distributions.
Henry T; Ödén J
Phys Med; 2018 Dec; 56():81-89. PubMed ID: 30473384
[TBL] [Abstract][Full Text] [Related]
14. Linear energy transfer weighted beam orientation optimization for intensity-modulated proton therapy.
Gu W; Ruan D; Zou W; Dong L; Sheng K
Med Phys; 2021 Jan; 48(1):57-70. PubMed ID: 32542711
[TBL] [Abstract][Full Text] [Related]
15. Mixed Effect Modeling of Dose and Linear Energy Transfer Correlations With Brain Image Changes After Intensity Modulated Proton Therapy for Skull Base Head and Neck Cancer.
Engeseth GM; He R; Mirkovic D; Yepes P; Mohamed ASR; Stieb S; Fuller CD; Wu R; Zhang X; Hysing LB; Pettersen HES; Stokkevåg CH; Mohan R; Frank SJ; Gunn GB
Int J Radiat Oncol Biol Phys; 2021 Nov; 111(3):684-692. PubMed ID: 34153379
[TBL] [Abstract][Full Text] [Related]
16. Comparing biological effectiveness guided plan optimization strategies for cranial proton therapy: potential and challenges.
Hahn C; Heuchel L; Ödén J; Traneus E; Wulff J; Plaude S; Timmermann B; Bäumer C; Lühr A
Radiat Oncol; 2022 Oct; 17(1):169. PubMed ID: 36273132
[TBL] [Abstract][Full Text] [Related]
17. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
Ödén J; Eriksson K; Toma-Dasu I
Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
[TBL] [Abstract][Full Text] [Related]
18. Linear energy transfer distributions in the brainstem depending on tumour location in intensity-modulated proton therapy of paediatric cancer.
Fjæra LF; Li Z; Ytre-Hauge KS; Muren LP; Indelicato DJ; Lassen-Ramshad Y; Engeseth GM; Brydøy M; Mairani A; Flampouri S; Dahl O; Stokkevåg CH
Acta Oncol; 2017 Jun; 56(6):763-768. PubMed ID: 28423966
[TBL] [Abstract][Full Text] [Related]
19. Can differences in linear energy transfer and thus relative biological effectiveness compromise the dosimetric advantage of intensity-modulated proton therapy as compared to passively scattered proton therapy?
Giantsoudi D; Adams J; MacDonald S; Paganetti H
Acta Oncol; 2018 Sep; 57(9):1259-1264. PubMed ID: 29726722
[TBL] [Abstract][Full Text] [Related]
20. Impact of RBE variations on risk estimates of temporal lobe necrosis in patients treated with intensity-modulated proton therapy for head and neck cancer.
Engeseth GM; Hysing LB; Yepes P; Pettersen HES; Mohan R; Fuller CD; Stokkevåg CH; Wu R; Zhang X; Frank SJ; Gunn GB
Acta Oncol; 2022 Feb; 61(2):215-222. PubMed ID: 34534047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]